+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Drug Discovery Market Size, Share & Trends Analysis Report by Application, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
Artificial Intelligence in Drug Discovery Market Size, Share & Trends Analysis Report by Application, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
New

Artificial Intelligence in Drug Discovery Market Size, Share & Trends Analysis Report by Application, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 100 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 5595828
REQUEST CUSTOMIZATION
Description Jump to:
The global artificial intelligence in drug discovery market size was estimated at USD 2.35 billion in 2025 and is projected to reach USD 13.77 billion by 2033, growing at a CAGR of 24.8% from 2026 to 2033. The rising demand for cost-effective drug development, the increasing number of clinical trials in drug repurposing, and the growing prevalence of chronic diseases are significant factors contributing to market growth.

In addition, the growing focus on precision medicine and targeted drug development, as well as improvements in computing power and cloud infrastructure, are other factors fueling market growth. The rising demand for cost-effective drug development strategies substantially drives the growth of artificial intelligence (AI) in the drug discovery industry. According to an article published in the Frontiers in Pharmacology Journal in October 2025, Traditional drug discovery involves lengthy timelines, often exceeding a decade, and costs frequently exceed USD 2 billion per drug. AI in drug discovery and repurposing offers a strategy to bypass early-stage safety testing by focusing on approved or investigational drugs for new indications. Drug repurposing is anticipated to reduce risks and bring drugs to the market in 3-12 years, with an average investment of USD 300 million.

AI accelerates this process by rapidly analyzing extensive biological, chemical, and clinical datasets to identify novel associations between drugs and diseases. This reduces development timelines and costs, offering pharmaceutical companies and healthcare providers an economically viable alternative to the development of new drugs. Integrating artificial intelligence with drug repurposing effectively addresses key industry challenges by enhancing productivity while reducing associated risks and investments. AI enhances this economic advantage by efficiently analyzing extensive chemical libraries, biomedical literature, omics datasets, and real-world evidence to identify a limited set of high-probability candidates, rather than supporting broad empirical screening.

Global Artificial Intelligence In Drug Discovery Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global artificial intelligence in drug discovery market report based on application, therapeutic area, end use, and region.

Application Outlook (Revenue, USD Million, 2021-2033)

  • Drug optimization and repurposing
  • Preclinical testing
  • Others

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Application Segment
1.2.2. Therapeutic Area
1.2.3. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for cost-effective drug development
3.2.1.2. Increasing clinical trials in drug repurposing
3.2.1.3. Growing focus on precision medicine and targeted drug development
3.2.2. Market restraint analysis
3.2.2.1. Highly regulated industry
3.2.2.2. High computational costs and infrastructure requirements
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Case Study Insights
3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
3.4.2.6. Social Landscape
Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.4. Drug optimization and repurposing
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Preclinical testing
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Others
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
5.4. Oncology
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Neurodegenerative Diseases
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Cardiovascular Disease
5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Metabolic Diseases
5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Infectious Disease
5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Contract Research Organizations (CROs)
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Academic and Research Institutes
6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Other
6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
8.4.1. Healx
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. BostonGene Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. BenevolentAI
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Innophore
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Delta4.ai
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. BioXcel Therapeutics Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. BullFrog AI Holdings, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Graphwise
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Owkin, Inc
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Insilico Medicine
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. IBM
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Exscientia
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Google (DeepMind)
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. BioSymetrics, Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. BPGbio Inc. (Berg Health)
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. Atomwise Inc.
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. Recursion
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives
8.4.18. Aitia
8.4.18.1. Company overview
8.4.18.2. Financial performance
8.4.18.3. Product benchmarking
8.4.18.4. Strategic initiatives
8.4.19. Insitro
8.4.19.1. Company overview
8.4.19.2. Financial performance
8.4.19.3. Product benchmarking
8.4.19.4. Strategic initiatives
List of Tables
Table 1 List Of Abbreviations
Table 2 Global Artificial Intelligence In Drug Discovery Market, By Region, 2021-2033 (USD Million)
Table 3 Global Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 4 Global Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 5 Global Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 6 North America Artificial Intelligence In Drug Discovery Market, By Country, 2021-2033 (USD Million)
Table 7 North America Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 8 North America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 9 North America Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 10 US Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 11 US Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 12 US Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 13 Canada Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 14 Canada Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 15 Canada Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 16 Mexico Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 17 Mexico Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 18 Mexico Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 19 Europe Artificial Intelligence In Drug Discovery Market, By Country, 2021-2033 (USD Million)
Table 20 Europe Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 21 Europe Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 22 Europe Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 23 UK Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 24 UK Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 25 UK Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 26 Germany Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 27 Germany Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 28 Germany Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 29 France Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 30 France Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 31 France Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 32 Italy Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 33 Italy Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 34 Italy Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 35 Spain Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 36 Spain Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 37 Spain Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 38 Denmark Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 39 Denmark Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 40 Denmark Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 41 Sweden Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 42 Sweden Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 43 Sweden Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 44 Norway Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 45 Norway Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 46 Norway Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 47 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Country, 2021-2033 (USD Million)
Table 48 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 49 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 50 Asia Pacific Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 51 China Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 52 China Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 53 China Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 54 Japan Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 55 Japan Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 56 Japan Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 57 India Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 58 India Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 59 India Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 60 South Korea Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 61 South Korea Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 62 South Korea Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 63 Australia Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 64 Australia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 65 Australia Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 66 Thailand Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 67 Thailand Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 68 Thailand Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 69 Latin America Artificial Intelligence In Drug Discovery Market, By Country, 2021-2033 (USD Million)
Table 70 Latin America Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 71 Latin America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 72 Latin America Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 73 Brazil Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 74 Brazil Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 75 Brazil Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 76 Argentina Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 77 Argentina Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 78 Argentina Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 79 MEA Artificial Intelligence In Drug Discovery Market, By Country, 2021-2033 (USD Million)
Table 80 MEA Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 81 MEA Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 82 MEA Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 83 South Africa Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 84 South Africa Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 85 South Africa Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 86 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 87 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 88 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 89 UAE Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 90 UAE Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 91 UAE Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
Table 92 Kuwait Artificial Intelligence In Drug Discovery Market, By Application, 2021-2033 (USD Million)
Table 93 Kuwait Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021-2033 (USD Million)
Table 94 Kuwait Artificial Intelligence In Drug Discovery Market, By End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Market formulation & validation
Figure 5 Artificial intelligence in drug discovery market: Market outlook
Figure 6 Artificial intelligence in drug discovery market: Segment outlook
Figure 7 Artificial intelligence in drug discovery market: Competitive landscape outlook
Figure 8 Parent market outlook
Figure 9 Artificial intelligence in drug discovery market driver impact
Figure 10 Artificial intelligence in drug discovery market restraint impact
Figure 11 Artificial intelligence in drug discovery market: Application outlook and key takeaways
Figure 12 Artificial intelligence in drug discovery market: Application movement analysis
Figure 13 Drug optimization and repurposing market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Preclinical testing market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Computer vision market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Artificial intelligence in drug discovery market: Therapeutic Area outlook and key takeaways
Figure 18 Artificial intelligence in drug discovery market: Therapeutic Area movement analysis
Figure 19 Oncology market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Neurodegenerative diseases market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Cardiovascular disease market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Metabolic diseases market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Infectious disease market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Artificial intelligence in drug discovery market: End use outlook and key takeaways
Figure 26 Artificial intelligence in drug discovery market: End use movement analysis
Figure 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Contract research organizations (CROs) market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Academic & research institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Global Artificial intelligence in drug discovery market: Regional outlook and key takeaways
Figure 32 Global Artificial intelligence in drug discovery market: Regional movement analysis
Figure 33 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 US key country dynamics
Figure 35 US market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Canada key country dynamics
Figure 37 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Mexico key country dynamics
Figure 39 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 UK key country dynamics
Figure 42 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Germany key country dynamics
Figure 44 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 France key country dynamics
Figure 46 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Italy key country dynamics
Figure 48 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Spain key country dynamics
Figure 50 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Denmark key country dynamics
Figure 52 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Sweden key country dynamics
Figure 54 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Norway key country dynamics
Figure 56 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Asia Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Japan key country dynamics
Figure 59 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 China key country dynamics
Figure 61 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 India key country dynamics
Figure 63 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Thailand key country dynamics
Figure 65 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 South Korea key country dynamics
Figure 67 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Australia key country dynamics
Figure 69 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Brazil key country dynamics
Figure 72 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 Argentina key country dynamics
Figure 74 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 South Africa key country dynamics
Figure 77 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Saudi Arabia key country dynamics
Figure 79 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 UAE key country dynamics
Figure 81 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Kuwait key country dynamics
Figure 83 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Artificial Intelligence in Drug Discovery market report include:
  • Healx
  • BostonGene Corporation
  • BenevolentAI
  • Innophore
  • Delta4.ai
  • BioXcel Therapeutics Inc.
  • BullFrog AI Holdings, Inc.
  • Graphwise
  • Owkin, Inc
  • Insilico Medicine
  • IBM
  • Exscientia
  • Google (DeepMind)
  • BioSymetrics, Inc.
  • BPGbio Inc. (Berg Health)
  • Atomwise Inc.
  • Recursion
  • Aitia
  • insitro

Table Information

Report AttributeDetails
No. of Pages100
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 2.35 Billion
Forecasted Market Value ( USD ) by 2033 $ 13.77 Billion
Compound Annual Growth Rate24.8%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

AI Drug Discovery Software Market - Global Forecast 2025-2030 - Product Image

AI Drug Discovery Software Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032 - Product Image

Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report

  • Report
  • 399 Pages
  • Global
From
AI in Drug Discovery Market Report 2026 - Product Image

AI in Drug Discovery Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Generative AI in Drug Discovery Market Report 2026 - Product Image

Generative AI in Drug Discovery Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.